Gene Query: NAPG

Dataset Description Geneva Score
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 43.41
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 43.41
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 23.63
RNA-seq of YB5 cells treated with Proscillaridin A 22.55
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 21.68
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 20.82
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 18.59
SUV420H2 knockdown in PANC-1 18.58
Cleavage Factor Im as a key regulator of 3’ UTR length 17.33
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 16.8
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 14.34
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 14.34
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 13.3
Nucleoporin-mediated regulation of cell identity genes 13.06
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 12.16
An siRNA screen identifies CHD4 as a target for epigenetic therapy 11.64
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 11.35
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 11.16
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 10.98
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 10.39
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 10.26
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 10.21
JunB control of keratinocyte-mediated inflammation [RNA-seq] 10.21
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 9.99
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 9.87
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 9.82
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 9.71
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 9.65
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 9.51
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 9.51
Control of prostate tumour growth by the long non-coding RNA GHSROS 9.37
WRN knockout effects upon gene expression in SW48 and OVK18 9.29
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 8.73
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 8.73
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 8.72
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 8.7
SLIGRL-induced gene expression changes in NHEK cells 8.55
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 8.5
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 8.5
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 8.41
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 8.35
EWSR1 influences alternative splicing through direct and indirect mechanisms 8.1
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 8.07
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 8.05
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 8.05
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 8.02
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 7.96
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 7.92
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 7.77
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 7.77
Crizotinib v. DMSO in SW480 cells 7.73
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 7.71
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 7.54
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 7.54
Effect of PRDM11 depletion in U2932 cells 7.33
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 7.32
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 7.23
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 7.23
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 7.1
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 7.1
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 7.06
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.05
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 7.05
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 6.66
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 6.45
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 6.38
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 6.31
Ribosomal footprinting of CN34-Parental and CN34-LM1a 6.2
RNA-seq of cells with TET1 knockout 6.11
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 6.07
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 6.07
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 6.01
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 6.01
Ribosomal footprinting of MDA-Parental and MDA-LM2 6.01
mRNA sequencing of oropharyngeal cancer cell lines 6.0
Genome-wide discovery of human splicing branchpoints 5.98
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 5.97
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 5.96
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 5.91
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 5.84
UBC9 knockdown in bladder cancer T24 cell lines 5.75
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 5.72
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 5.7
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 5.58
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 5.56
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 5.46
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 5.42
Neonatal and adult human testis defined at the single-cell level 5.31
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 5.3
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 5.28
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 5.27
TGF-β regulation of miRNA expression in pancreatic cancer 5.25
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 5.22
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 5.19
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 5.19
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 5.14
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 5.1
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 4.98
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 4.93
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 4.87
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 4.83
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 4.83
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 4.79
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 4.79
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 4.75
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.75
T47D RNA-seq and ChrRNA-seq data 4.67
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 4.67
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 4.66
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 4.65
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 4.64
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.63
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 4.63
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 4.62
RNAseq analysis of ESRP regulated splicing events in prostate cancer 4.61
TCF7L1 knockdown in pancreatic cancer 4.56
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 4.55
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 4.54
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 4.54
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 4.5
RNA sequencing analysis of selumetinib-resistant CRC cells lines 4.44
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 4.44
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.42
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.42
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 4.41
RNA-seq analysis of differentiating human erythroblasts 4.39
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 4.37
Cajal bodies are linked to genome conformation [RNA-Seq] 4.37
Cajal bodies are linked to genome conformation 4.37
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.34
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 4.32
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 4.32
Developmental stage specific chromosome architecture in human erythroid cells 4.32
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 4.32
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 4.31
RNA-Seq from early time points in the kidney differentiation protocol 4.28
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.28
MicroRNA-125a-5p overexpression in human macrophages 4.26
RNA-seq analysis and shRNA screen of breast cancer 4.24
RNA-seq analysis of breast cancer 4.24
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 4.24
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 4.21
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 4.17
CROP-Seq in Primary Human T Cells 4.16
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 4.14
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 4.13
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 4.1
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 4.1
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 4.08
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 4.05
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 4.05
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 4.05
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 4.04
BAF controls genome accessibility 4.04
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 4.03
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.03
Effect of PBK knockdown on C4-2 cell transcriptome 4.02
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 4.02
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 4.02
Disruption of the exocyst induces podocyte loss and dysfunction 4.0
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 4.0
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 3.98
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 3.98
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 3.97
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 3.97
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 3.93
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.93
K562 polyA RNA-Seq 3.93
Spliceosomal disruption of the non-canonical BAF complex in cancer 3.93
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 3.92
KSDM1b Role in Ewing Sarcoma 3.91
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 3.88
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 3.87
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 3.87
Total RNA-seq in ALL-SIL upon TLX1 knockdown 3.86
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 3.85
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 3.79
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 3.77
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.77
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 3.76
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 3.73
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 3.73
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 3.7
RNAseq in Alzheimer's Disease patients 3.69
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 3.67
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 3.67
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 3.66
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 3.66
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 3.65
Gene expression in GBM with Cav3.2 inhibition 3.64
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 3.64
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 3.63
Metastasis in triple-negative breast cancer 3.62
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 3.62
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 3.61
Transcriptomic analysis of LSD1 3.6
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 3.59
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 3.56
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 3.55
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 3.55
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.53
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 3.52
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 3.46
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.44
Genome-wide discovery of human splicing branchpoints [RNAse] 3.41
R430: A potent inbibitor of DNA and RNA viruses 3.4
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 3.35
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 3.34
Exploring the RNA landscape of endothelial exosomes 3.33
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 3.27
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.27
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 3.27
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 3.27
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 3.24
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 3.23
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 3.22
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 3.22
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.2
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 3.19
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 3.15
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 3.15
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 3.14
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 3.1
Selective expression of long non-coding RNAs in a breast cancer cell progression model 3.07
The role of the Calcium-Sensing receptor in colorectal cancer 3.07
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 3.07
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 3.07
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 3.03
RNAseq of T-ALL upon long non coding rna purturbation 3.01
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 3.01
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 2.99
Transcriptional profile in human S. haematobium infection 2.98
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 2.93
Transcriptomic analysis of the HOTAIR-regulated genes 2.91
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 2.88
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.87
CDK4/6 inhibitor resistance in prostate cancer 2.87
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 2.83
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 2.83
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.78
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 2.76
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 2.75
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 2.74
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.73
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 2.72
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 2.72
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.71
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 2.7
HBEC-shp53-PCHD7 2.69
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.67
Interaction between mitoNEET and NAF-1 in cancer cells 2.63
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 2.62
Illumina Total RNA-seq in HeLa 2.61
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 2.58
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.57
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 2.56
Alteration of the microRNA network during the progression of Alzheimer’s disease 2.56
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 2.55
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 2.55
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 2.55
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 2.5
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 2.49
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 2.45
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 2.42
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.38
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.38
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 2.33
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 2.32
Effect of BB608 on Gene Expression in HNSCC Cell Line 2.32
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 2.31
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 2.3
Human neutrophil genome during PMA- and E. coli encounter-induced activation 2.27
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 2.27
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 2.17
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.14
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 2.11
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 2.11
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 2.1
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 2.09
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 2.08
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.06
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 2.06
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.06
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.05
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 2.05
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 2.04
Role of FGFR1 in neuronal devlopment 2.03
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 2.03
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 2.02
Functional significance of the HIV-1 Tat signature amino acid residues 2.01
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.01
Discovering human diabetes-risk gene function with genetics and physiological assays 1.96
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 1.95
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 1.93
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.93
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 1.89
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.88
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 1.88
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.87
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 1.85
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 1.85
Fusion discovery in breast cancer cell line 1.84
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.84
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.84
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.84
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.84
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.82
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 1.82
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 1.81
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.81
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.8
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.8
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 1.78
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 1.78
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 1.77
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 1.72
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 1.71
HNRNPM-regulated splicing dependencies in prostate cancer 1.71
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.71
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.69
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.68
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.65
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.65
Real-time observation of light-controlled transcription in living cells 1.65
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.61
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.61
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.6
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 1.56
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 1.56
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 1.53
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.53
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 1.52
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.51
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 1.49
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 1.48
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.48
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.46
In vitro modeling of human germ cell development using pluripotent stem cells 1.45
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.43
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.43
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 1.42
Human Treg NaCl stimulation 1.4
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.4
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 1.38
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 1.38
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.34
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.34
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.34
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.29
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.28
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 1.27
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.26
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.25
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.25
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.23
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.23
The age and genomic integrity of neurons after cortical stroke in humans 1.22
PTHrP overexpression in MCF7 cells 1.21
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.21
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.21
The gene expression profiles of gallbladder cancer 1.19
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.19
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 1.17
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 1.17
In situ CAPTURE of chromatin interactions by biotinylated dCas9 1.17
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.16
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.15
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 1.13
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 1.13
Expression profiling of MCF-7 cells with treatment of TCDD 1.13
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 1.13
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.1
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 1.09
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 1.09
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.06
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.06
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.05
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.05
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.03
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 1.03
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.0
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.0
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.99
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 0.97
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.94
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.93
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 0.92
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.9
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.9
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 0.89
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.88
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.87
Transcriptome-wide modulation of splicing by the exon junction complex 0.86
quanTIseq: quantifying immune contexture of human tumors 0.86
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.85
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.85
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.85
HEK293 Heat-shock experiment 0.84
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.83
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 0.82
BET bromodomain inhibition 0.82
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.81
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 0.81
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.81
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.8
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.78
UV_24h_GRO-Seq 0.77
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 0.75
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 0.75
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.73
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.71
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.71
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.71
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.7
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.7
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.7
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.69
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.68
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 0.68
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.68
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.67
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.66
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.66
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.66
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.66
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.66
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 0.64
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.63
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.63
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.63
Aging-associated patterns in the expression of human endogenous retroviruses 0.62
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.62
RNA-seq of cancer cell lines treated with T-025 0.61
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 0.6
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.59
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.58
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.56
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.53
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.53
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.53
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.53
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.52
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.51
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.48
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.48
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.48
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.48
Genome-wide analysis of the Integrator complex 0.46
Genome-wide analysis of the Integrator complex (HTS) 0.46
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 0.46
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 0.45
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.45
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 0.44
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.43
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.43
Dilated cardiomyopathy vs Myocarditis 0.42
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.4
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.37
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  0.36
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.36
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.34
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.33
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.33
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.31
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.31
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.27
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 0.26
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.26
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 0.25
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.25
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.23
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.23
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.22
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 0.2
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.19
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.17
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 0.17
Identification of long noncoding RNAs regulated by p53 0.13
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 0.12
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.12
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.11
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.11
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.1
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.1
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.1
Human Tfh cell RNA bulk sequencing 0.1
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.09
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.09
p53 activity results in DNA replication fork processivity 0.09
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.09
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.09
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.08
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.08
A single-cell transcriptome atlas of the human pancreas 0.07
Oncogenic roles of ARID5B in T-ALL 0.07
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.07
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 0.06
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.06
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.05
Interphase condensins regulate ligand-depedent enhancer activation 0.05


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation